Hematologic Outcomes of COVID-19 Patients with and without G6PD Deficiency: A Comparative Study

Mostrar otras versiones (1)

Introduction: Patients with multiple comorbidities who have coronavirus disease 2019 (COVID-19) have high morbidity and mortality. Glucose-6-phosphate dehydrogenase (G6PD) deficiency has been shown to have an enhanced effect on coronavirus in an earlier study. Methods: We conducted this comparative...

Descripción completa

Detalles Bibliográficos
Autores principales: Mushtaq, Kamran, Soliman, Ashraf T., Nashwan, Abdulqadir J., Iqbal, Fatima, Karawia, Ahmed A., Ahmed, Doaa H., Hailan, Yousef M., Alawad, Mouhammad J., Abubakar, Muhammad, Gul, Mohammadshah I., Ata, Fateen, Seijari, Mohammed N., Elhadi, Mohammed E., Kaspo, Samer J., Yassin, Mohamed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: HBKU Press 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676944/
https://www.ncbi.nlm.nih.gov/pubmed/36466438
http://dx.doi.org/10.5339/qmj.2022.54
Mostrar todas las versiones(2)

Ejemplares similares